SCHEMBL17084371

SCHEMBL17084371

C/C=C/C(=O)c1ccc2c(c1)C(CCC)(CCC)c1cc(Br)ccc1-2

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ THRA P10827 1/20 0.39
▸ THRB P10828 1/20 0.39
▸ LMNA P02545 5/20 0.35
▸ RECQL P46063 2/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ ALDH1A1 P00352 7/20 0.34
▸ MAPT P10636 5/20 0.34
▸ HTT P42858 3/20 0.34
▸ MEN1 O00255 2/20 0.34
▸ POLB P06746 2/20 0.34
▸ KMT2A Q03164 2/20 0.34
▸ TLR9 Q9NR96 2/20 0.34
▸ TDP1 Q9NUW8 2/20 0.34
▸ L3MBTL1 Q9Y468 2/20 0.34
▸ USP2 O75604 1/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ MAOB P27338 1/20 0.34
▸ ATM Q13315 2/20 0.33
▸ ALPG P10696 1/20 0.33
▸ NPSR1 Q6W5P4 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5049195 0.83 PDK2 (0.42) LMNARAB9AMAPTMEN1POLB
SCHEMBL27584898 0.82 MAPT (0.37) ALDH1A1MAPTHTTPOLBKMT2A
SCHEMBL1993181 0.79 PDK2 (0.39) RAB9AMEN1KMT2ASMN1; SMN2CA1
SCHEMBL29375527 0.79 PDK2 (0.39) RAB9AMEN1KMT2ASMN1; SMN2CA1
SCHEMBL14011691 0.77 MAPT (0.39) LMNARAB9AMAPTMEN1KMT2A
SCHEMBL29294962 0.76 PDK2 (0.37) RAB9AMEN1KMT2ASMN1; SMN2CA1
SCHEMBL17084369 0.75 P4HB (0.35) THRATHRBLMNARECQLRAB9A
SCHEMBL18012808 0.74 MAPT (0.38) LMNAALDH1A1MAPTMEN1KMT2A
SCHEMBL27880402 0.74 PARP1 (0.43) RAB9AALDH1A1MAPTMEN1KMT2A
SCHEMBL17084354 0.74 THRA (0.44) THRATHRBRECQLTDP1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9684238-B2 Fluorene-type compound, photopolymerization initiator comprising said fluorene-type compound, and photosensitive composition containing said photopolymerization initiator TOKYO OHKA KOGYO CO., LTD. (JP) 2017-06-20 — — US disclosed
US-9684238-B2 Fluorene-type compound, photopolymerization initiator comprising said fluorene-type compound, and photosensitive composition containing said photopolymerization initiator TOKYO OHKA KOGYO CO., LTD. (JP) 2017-06-20 — — US disclosed
US-20150259321-A1 FLUORENE-TYPE COMPOUND, PHOTOPOLYMERIZATION INITIATOR COMPRISING SAID FLUORENE-TYPE COMPOUND, AND PHOTOSENSITIVE COMPOSITION CONTAINING SAID PHOTOPOLYMERIZATION INITIATOR DAITO CHEMIX CORPORATION (JP) 2015-09-17 — — US disclosed
US-20150259321-A1 FLUORENE-TYPE COMPOUND, PHOTOPOLYMERIZATION INITIATOR COMPRISING SAID FLUORENE-TYPE COMPOUND, AND PHOTOSENSITIVE COMPOSITION CONTAINING SAID PHOTOPOLYMERIZATION INITIATOR DAITO CHEMIX CORPORATION (JP) 2015-09-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150259321-A1 FLUORENE-TYPE COMPOUND, PHOTOPOLYMERIZATION INITIATOR COMPRISING SAID FLUORENE-TYPE COMPOUND, AND PHOTOSENSITIVE COMPOSITION CONTAINING SAID PHOTOPOLYMERIZATION INITIATOR AFF1, AFF2, FTO THRA 4685/4885THRB 4835/4885LMNA 3161/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback